YolTech Therapeutics, a biotech company pioneering in in vivo gene editing therapies, today announced participation in TIDES Asia 2024, March 19th to 21st, 2024, at the Westin Miyako Kyoto in Kyoto, Japan.
SHANGHAI, March 13, 2024 /PRNewswire/ -- YolTech Therapeutics, a biotech company pioneering in in vivo gene editing therapies, today announced participation in TIDES Asia 2024, March 19th to 21st, 2024, at the Westin Miyako Kyoto in Kyoto, Japan. TIDES Asia, a conference in Asia that brings together discovery, clinical, delivery and CMC/manufacturing experts developing therapeutics/vaccines using modalities of Oligonucleotides, Peptides, mRNA and Genome Editing. Attendees from US, Europe and Asia come together to share scientific strategies and common challenges to help accelerate new molecules to market. YolTech Therapeutics’ representatives will bring latest advancements in in vivo gene editing technology and innovative LNP deliver system during the conference. Sincerely invites partners, investors, and stakeholders to join the session at TIDES Asia 2024 to share views of our breakthroughs. Details are as follows: Date: Wednesday, March 20, 2024 About YolTech For more information, please visit: www.yoltx.com or follow YolTech on LinkedIn https://www.linkedin.com/company/yoltech-therapeutics/ CONTACT: Wei Lu, weilu@yoltx.com View original content:https://www.prnewswire.com/news-releases/yoltech-therapeutics-to-showcase-breakthroughs-in-in-vivo-gene-editing-at-tides-asia-2024-302087788.html SOURCE YolTech Therapeutics |